MANA MCCLAIN: Open Payments
NPI 1104418854 · SWAMPSCOTT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 14 payments from 7 companies in 2025. Trend: 2023 $1,091 · 2024 $755 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $163 |
| GENZYME CORPORATION | 1 | $132 |
| Janssen Biotech, Inc. | 3 | $100 |
| Lilly USA, LLC | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Amgen Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: Bimzelx, DUPIXENT, TREMFYA, TALTZ, Sotyktu, Otezla, EBGLYSS, COSENTYX.
Industry payments across MA — which companies pay providers there.
